Conmed (CNMD) Dividends Paid - Common Growth (3y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.25% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.26% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.52% |
| Sep 30, 2025 | 0.53% |
| Jun 30, 2025 | 1.60% |
| Mar 31, 2025 | 1.71% |
| Dec 31, 2024 | 1.90% |
| Sep 30, 2024 | 1.87% |
| Jun 30, 2024 | 1.94% |
| Mar 31, 2024 | 2.14% |
| Dec 31, 2023 | 2.45% |
| Sep 30, 2023 | 2.47% |
| Jun 30, 2023 | 2.32% |
| Mar 31, 2023 | 2.38% |
| Dec 31, 2022 | 2.42% |
| Sep 30, 2022 | 2.49% |
| Jun 30, 2022 | 1.49% |
| Mar 31, 2022 | 1.45% |
| Dec 31, 2021 | 1.25% |
| Sep 30, 2021 | 1.22% |
| Jun 30, 2021 | 1.22% |
| Mar 31, 2021 | 1.08% |
| Dec 31, 2020 | 0.79% |
| Sep 30, 2020 | 0.76% |
| Jun 30, 2020 | 0.78% |
| Mar 31, 2020 | 0.70% |
| Dec 31, 2019 | 0.65% |
| Sep 30, 2019 | 0.58% |
| Jun 30, 2019 | 0.58% |
| Mar 31, 2019 | 0.50% |
| Dec 31, 2018 | 0.50% |
| Sep 30, 2018 | 0.49% |
| Jun 30, 2018 | 0.54% |
| Mar 31, 2018 | 0.49% |
| Dec 31, 2017 | 0.49% |
| Sep 30, 2017 | 0.70% |
| Jun 30, 2017 | 0.79% |
| Mar 31, 2017 | 0.13% |
| Dec 31, 2016 | 10.46% |
| Sep 30, 2016 | 10.49% |
| Jun 30, 2016 | 9.81% |
| Mar 31, 2016 | 9.20% |
| Dec 31, 2015 | 9.05% |
| Sep 30, 2015 | 8.81% |
| Jun 30, 2015 | 8.66% |